#BEGIN_DRUGCARD DB04548

# AHFS_Codes:
Not Available

# ATC_Codes:
Not Available

# Absorption:
Not Available

# Biotransformation:
Not Available

# Brand_Mixtures:
Not Available

# Brand_Names:
Not Available

# CAS_Registry_Number:
Not Available

# ChEBI_ID:
Not Available

# Chemical_Formula:
C6H10O6

# Chemical_IUPAC_Name:
(2S,4S,5R,6R)-4,5,6-trihydroxyoxane-2-carboxylic acid

# Chemical_Structure:
Not Available

# Creation_Date:
2005-06-13 07:24:05 -0600

# DPD_Drug_ID_Number:
Not Available

# Description:
Not Available

# Dosage_Forms:
Not Available

# Drug_Category:
Not Available

# Drug_Interactions:
Not Available

# Drug_Reference:
Not Available

# Drug_Type:
Experimental
Small Molecule

# Experimental_Caco2_Permeability:
Not Available

# Experimental_LogP_Hydrophobicity:
Not Available

# Experimental_Logs:
Not Available

# Experimental_Water_Solubility:
Not Available

# Food_Interactions:
Not Available

# GenBank_ID:
Not Available

# Generic_Name:
4-Deoxy-D-Glucuronic Acid

# HET_ID:
GC4

# Half_Life:
Not Available

# InChI_Identifier:
InChI=1S/C6H10O6/c7-2-1-3(5(9)10)12-6(11)4(2)8/h2-4,6-8,11H,1H2,(H,9,10)/t2-,3-,4+,6+/m0/s1

# InChI_Key:
InChIKey=OGDYCNQXUUBOMI-RFPGKLGKSA-N

# Indication:
Not Available

# KEGG_Compound_ID:
Not Available

# KEGG_Drug_ID:
Not Available

# LIMS_Drug_ID:
4548

# Mechanism_Of_Action:
Not Available

# Melting_Point:
Not Available

# Molecular_Weight_Avg:
178.14

# Molecular_Weight_Mono:
178.047738052

# Organisms_Affected:
Not Available

# PDB_Experimental_ID:
1I8Q

# PDB_Homology_ID:
Not Available

# PDRhealth_Link:
Not Available

# Pathways:
Not Available

# PharmGKB_ID:
Not Available

# Pharmacology:
Not Available

# Predicted_LogP_Hydrophobicity:
-2.2

# Predicted_LogS:
0.42

# Predicted_Water_Solubility:
4.72e+02 g/l

# Primary_Accession_No:
DB04548

# Protein_Binding:
Not Available

# PubChem_Compound_ID:
446228

# PubChem_Substance_ID:
46506544

# RxList_Link:
Not Available

# Salts:
Not Available

# Secondary_Accession_No:
EXPT01554

# Smiles_String_canonical:
Not Available

# Smiles_String_isomeric:
O[C@H]1C[C@H](O[C@@H](O)[C@@H]1O)C(O)=O

# State:
solid

# Structure:
1

# SwissProt_ID:
Not Available

# SwissProt_Name:
Not Available

# Synonyms:
Not Available

# Synthesis_Reference:
Not Available

# Toxicity:
Not Available

# Update_Date:
2013-02-08 16:23:27 -0700

# Wikipedia_Link:
Not Available

# pKa_Isoelectric_Point:
Not Available

# Drug_Target_1_Cellular_Location:
Secreted protein

# Drug_Target_1_Chromosome_Location:
Not Available

# Drug_Target_1_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_1_Essentiality:
Non-Essential

# Drug_Target_1_GenAtlas_ID:
Not Available

# Drug_Target_1_GenBank_ID_Gene:
U15050

# Drug_Target_1_GenBank_ID_Protein:
595847

# Drug_Target_1_GeneCard_ID:
Not Available

# Drug_Target_1_Gene_Name:
hylB

# Drug_Target_1_Gene_Sequence:
>2955 bp
ATGAAACAAGTAGTAGATAATCAAACTCAAAATAAGGAGCTGGTGAAAAACGGAGATTTT
AATCAAACTAACCCTGTATCTGGAAGCTGGTCACATACAAGCGCTAGGGAATGGTCTGCT
TGGATTGATAAAGGAAATACTGCTGATAAATCACCTATTATCCAACGTACCGAACAAGGC
CAAGTAAGTCTATCCAGCGACAAAGGCTTTAGAGGTGCTGTAACACAAAAAGTGAACATT
GATCCCACTAAAAAATATGAGGTTAAGTTTGATATTGAAACAAGTAACAAGGCTGGACAA
GCTTTCCTTCGTATTATGGAGAAAAAAGACAACAATACGCGACTTTGGCTTTCTGAGATG
ACCAGCGGTACTACTAACAAACATACCTTAACAAAGATATATAACCCAAAGTTAAATGTC
TCCGAGGTGACACTTGAACTTTATTATGAAAAAGGAACTGGTTTTGTTACTTTTGATAAT
ATATCAATGAAAGCAAAAGGCCCTAAAGACTCAGAGCATCCACAACCCGTCACAACACAA
ATTGAAAAAAGCGTTAATACGGCTTTAAACAAAAATTACGTTTTTAATAAAGCTGACTAC
CAATACACTCTAACCAATCCGTCTCTTGGGAAAATTGTTGGGGGAATATTGTATCCAAAC
GCTACTGGTTCAACAACTGTTAAAATATCTGATAAATCTGGGAAAATAATTAAAGAAGTA
CCGTTATCAGTTACAGGTTCACCAGAAGATAACTTTACAAAACTCCTCGACAAATGGAAC
GACGTGACTATTGGTAATTATGTTTACGATACTAATGATTCGAACATGCAAAAGCTTACT
CAGAAATTAGATGAAACTAACGGCAAAAACATCGAAGCTATCAAACTGGATTCTAATCGC
ACTTTCCTTTGGAAAGATTTAGATAATCTCAATAATTCAGCACAGTTAACCGCTACTTAT
CGTCGTTTGGAAGATTTAGCTAAACAAATCACCAATCCACACTCTACTATTTACAAAAAT
GAAAAAGCTATTCGTACTGTAAAAGAGAGTCTGGCTTGGCTTCATCAGAACTTCTACAAT
GTTAATAAAGATATAGAAGGCTCTGCCAATTGGTGGGATTTTGAAATCGGTGTTCCTCGC
TCAATTACAGGTACCCTATCTCTCATGAATAACTACTTCACTGACGCTGAAATAAAAACT
TATACCGACCCAATTGAACACTTTGTTCCTGATGCAGAATATTTCCGTAAAACGCTTGTC
AATCCATTTAAAGCCCTTGGTGGTAATCTAGTAGATATGGGGCGCGTTAAAATCATTGAA
GGTTTACTTCGTAAAGACAATACTATTATCGAAAAAACTTCTCATTCTCTAAAAAATCTT
TTTACTACTGCTACTAAAGCTGAAGGCTTCTATGCTGACGGTTCTTACATCGACCATACA
AATGTTGCTTATACTGGCGCCTATGGTAATGTTCTGATAGATGGTTTGACACAATTGCTG
CCTATCATTCAAGAAACTGACTATAAAATCTCTAATCAAGAACTTGATATGGTTTATAAA
TGGATTAATCAATCATTTTTACCTTTAATTGTAAAAGGTGAGTTAATGGATATGAGTCGT
GGACGCTCAATTAGTAGAGAGGCAGCTTCTTCGCATGCGGCTGCAGTTGAAGTTCTCAGA
GGTTTCCTCAGATTGGCTAACATGTCTAATGAAGAGCGAAACTTAGACCTCAAATCAACT
ATTAAAGCGATTATCACTTCAAATAAATTCTACAATGTCTTCAATAACCTCAAATCGTAT
TCCGATATTGCCAACATGAATAAGCTGCTTAATGACAGTACAGTCGCTACTAAACCTTTA
AAAAGTAATTTATCAACCTTTAATAGCATGGACCGCTTAGCTTATTATAATGCCAAGAAA
GACTTTGGTTTCGCGCTTTCATTACATTCTAAACGTACCCTCAACTATGAAGGAATGAAT
GATGAAAATACACGTGGTTGGTATACCGGAGATGGTATGTTCTATATTTATAATAGTGAT
CAATCTCATTATAGTAATCATTTGGGGCCAACCGTCAATCCTTATAAAATGGCTGGAACA
ACTGAAAAAGATGCTAAGCGTGAAGATACCACTAAGGAATTCATGAGCAAACATAGCAAA
GACGCTAAAGAAAAAACCGGTCAAGTTACAGGAACATCTGACTTTGTTGGTTCCGTCAAA
CTTAATGATCACTTTGCTCTTGCCGCTATGGATTTTACTAACTGGGATCGCACCTTAACA
GCACAAAAAGGTTGGGTTATCTTAAATGATAAGATTGTCTTTTTAGGTAGCAACATCAAG
AATACTAACGGCATTGGAAATGTTTCTACAACAATTGATCAACGAAAAGACGATTCTAAA
ACACCTTATACTACATACGTCAATGGAAAAACTATTGATTTAAAACAAGCAAGTTCTCAA
CAATTTACAGATACAAAAAGTGTCTTTTTAGAATCAAAAGAACCTGGTCGCAATATTGGT
TATATCTTCTTTAAAAATAGCACTATTGATATTGAACGCAAAGAGCAAACAGGTACTTGG
AACAGCATTAATCGTACTTCTAAAAATACCTCAATCGTTAGCAATCCTTTTATCACTATA
AGCCTTAAGCATGACAACAAAGGTGATAGCTATGGTTACCTGATGGTTCCAAACATTGAT
CGCACTAGTTTTGATAAATTAGCCAACAGCAAAGAAGTAGAATTACTAGAAAATAGTTCA
AAACAACAAGTTATCTATGATAAAAACAGTCAAACTTGGGCTGTTATCAAACACGATAAT
CAAGAGAGTCTCATTAACAATCAATTCAAAATGAATAAAGCGGGACTTTACCTAGTACAA
AAAGTTGGTAATGACTATCAAAATGTCTATTACCAACCTCAAACCATGACAAAAACAGAC
CAATTAGCTATCTAA

# Drug_Target_1_General_Function:
Involved in hyaluronidase activity

# Drug_Target_1_General_References:
12354221	Glaser P, Rusniok C, Buchrieser C, Chevalier F, Frangeul L, Msadek T, Zouine M, Couve E, Lalioui L, Poyart C, Trieu-Cuot P, Kunst F: Genome sequence of Streptococcus agalactiae, a pathogen causing invasive neonatal disease. Mol Microbiol. 2002 Sep;45(6):1499-513.
7982914	Lin B, Hollingshead SK, Coligan JE, Egan ML, Baker JR, Pritchard DG: Cloning and expression of the gene for group B streptococcal hyaluronate lyase. J Biol Chem. 1994 Dec 2;269(48):30113-6.

# Drug_Target_1_HGNC_ID:
Not Available

# Drug_Target_1_HPRD_ID:
Not Available

# Drug_Target_1_ID:
3172

# Drug_Target_1_Locus:
Not Available

# Drug_Target_1_Molecular_Weight:
111582

# Drug_Target_1_Name:
Hyaluronate lyase

# Drug_Target_1_Number_of_Residues:
984

# Drug_Target_1_PDB_ID:
1LXM

# Drug_Target_1_Pathway:
Not Available

# Drug_Target_1_Pfam_Domain_Function:
PF02278	Lyase_8
PF02884	Lyase_8_C
PF08124	Lyase_8_N

# Drug_Target_1_Protein_Sequence:
>Hyaluronate lyase precursor
MKQVVDNQTQNKELVKNGDFNQTNPVSGSWSHTSAREWSAWIDKENTADKSPIIQRTEQG
QVSLSSDKGFRGAVTQKVNIDPTKKYEVKFDIETSNKAGQAFLRIMEKKDNNTRLWLSEM
TSGTTNKHTLTKIYNPKLNVSEVTLELYYEKGTGSATFDNISMKAKGPKDSEHPQPVTTQ
IEESVNTALNKNYVFNKADYQYTLTNPSLGKIVGGILYPNATGSTTVKISDKSGKIIKEV
PLSVTASTEDKFTKLLDKWNDVTIGNHVYDTNDSNMQKINQKLDETNAKNIKTIKLDSNH
TFLWKDLDNLNNSAQLTATYRRLEDLAKQITNPHSTIYKNEKAIRTVKESLAWLHQNFYN
VNKDIEGSANWWDFEIGVPRSITATLALMNNYFTDAEIKTYTDPIEHFVPDAGYFRKTLD
NPFKALGGNLVDMGRVKIIEGLLRKDNTIIEKTSHSLKNLFTTATKAEGFYADGSYIDHT
NVAYTGAYGNVLIDGLTQLLPIIQETDYKISNQELDMVYKWINQSFLPLIVKGELMDMSR
GRSISREAASSHAAAVEVLRGFLRLANMSNEERNLDLKSTIKTIITSNKFYNVFNNLKSY
SDIANMNKMLNDSTVATKPLKSNLSTFNSMDRLAYYNAEKDFGFALSLHSKRTLNYEGMN
DENTRDWYTGDGMFYLYNSDQSHYSNHFWPTVNPYKMAGTTEKDAKREDTTKEFMSKHSK
DAKEKTGQVTGTSDFVGSVKLNDHFALAAMDFTNWDRTLTAQKGWVILNDKIVFLGSNIK
NTNGIGNVSTTIDQRKDDSKTPYTTYVNGKTIDLKQASSQQFTDTKSVFLESKEPGRNIG
YIFFKNSTIDIERKEQTGTWNSINRTSKNTSIVSNPFITISQKHDNKGDSYGYMMVPNID
RTSFDKLANSKEVELLENSSKQQVIYDKNSQTWAVIKHDNQESLINNQFKMNKAGLYLVQ
KVGNDYQNVYYQPQTMTKTDQLAI

# Drug_Target_1_Reaction:
Cleaves hyaluronate chains at a beta-D-GalNAc-(1->4)-beta-D-GlcA bond, ultimately breaking the polysaccharide down to 3-(4-deoxy-beta-D-gluc-4-enuronosyl)-N-acetyl-D-glucosamine

# Drug_Target_1_Signals:
1-40

# Drug_Target_1_Specific_Function:
Cleaves hyaluronate chains at a beta-D-GalNAc- (1->4)-beta-D-GlcA bond, ultimately breaking the polysaccharide down to 3-(4-deoxy-beta-D-gluc-4-enuronosyl)-N-acetyl-D- glucosamine

# Drug_Target_1_SwissProt_ID:
Q53591

# Drug_Target_1_SwissProt_Name:
HYSA_STRA3

# Drug_Target_1_Synonyms:
EC 4.2.2.1
HYase
Hyaluronate lyase precursor
Hyaluronidase

# Drug_Target_1_Theoretical_pI:
8.99

# Drug_Target_1_Transmembrane_Regions:
None

# Drug_Target_2_Cellular_Location:
Not Available

# Drug_Target_2_Chromosome_Location:
Not Available

# Drug_Target_2_Drug_References:
Not Available

# Drug_Target_2_Essentiality:
Non-Essential

# Drug_Target_2_GenAtlas_ID:
Not Available

# Drug_Target_2_GenBank_ID_Gene:
AB011415

# Drug_Target_2_GenBank_ID_Protein:
Not Available

# Drug_Target_2_GeneCard_ID:
Not Available

# Drug_Target_2_Gene_Name:
aly

# Drug_Target_2_Gene_Sequence:
>1926 bp
TCAGCTCGAGTGCTTTACGTCGAGCTTGTACAACTTGACCAGCGCGCTGGTGTCCGACCC
GTCAGCCTGGCGGTCCTGCAAGTAATTGCCCGCCTTGAAATAGAACTTCAGGTCTTTCCA
GCCGGCGTCCTTGGCGACGAAATCGACGGTCTTGGTCTGCCCGTTGACCGTCATCGACAA
CACACCGTCCACCACTTTGATCTGCGCATCGTACGGCTTGCCCAGTTCGATGCCTTCGAA
CACGTAGTGCGTGTCCTTGCCGCCAGCGGCCGAGTTCTTCACAAGAAAATCCAGCGTGTT
CTTGTAGAACTGCCCCTTGACCAGCGGCGGCGCATTCGAGCCATCGGGCATGACGGCATG
AATCTGCATGACAATGGTCTTGCCACTGGGCGACACGTGCATCACCGCTCCGCGCAGATT
CATTTCGTGGGTGCCTTGCCAGCCCCAATTCACCGCGTGGTTGTCGGGATCGAGCATTTC
GCGCAGCTCGCTGCGCGGGTACTTCGTGTTGGCCGTCGTCTTGAAACCGCTGGCCGGACA
CCAGAAGGCAAGCGAGCCATCCTTGTCGACGTAGAAGTACTTGTCCTGATAACCCTTGAG
CAGATCACGCGTGGCGACATCGATCGGGTCGACCGGAATCTGCAGCTTCCACTTCGACAG
GTCGATCGACGAATGCGCCGCTGCCGGGGCGGACACCGGCGCCTGCGCTGCCGCGCCTTG
CGGTTTGTACGCCAGCAAAGTGCCCGAACCACCGGTACGCGGATCGAAGATCGGCACCGT
CATGAAGCCCAGCTCATCGGCAAAACCAAAGCGCGCGCGCTGGTATTCGATCCAGTTCAG
GTCGCCCCGCCCCGGCTTGAAGGCACGCGTATCCTGCGGCTCGGAAGCGTACTTCTTGAT
GAGGTCCGGGTTCTTCACCGCAGCAAAGACAAACTTGCGCGCTGAGTGAATATCGCGACC
GTTCTCTTTGTACGCGTACAGATCGATACCCTGACGTGATGCCGTTTCGGCAATCATCGT
CAGCGGCAGCATGGCGTAGTTCTGATAGTGCAAGGACTGTTCGTGACGCGTCATTTCATG
CACGAAGCTGCCGTCTTCATTGATCAGCCCCATCGCCTGCACATAACGGCCCAGCCCCCA
ACGGAAGAGTTCATCGTCCTTGCTGATCACGCCGATGATGGTCGCTTCCTGACCGCGCCA
ATACGAGTGATTGTTGCAGCAACTCGTGTCGCCCCCCGGAAAGCTCGTCTGATGGCGCGC
CACACGGTTGAGCCACTTCACCACACGCTCGCGCTGGGCTGTGTCGACGTTCGGCTCGGC
CATCATCGTCGACAGGGCAAAGGCGGCGGTCGCCGCCGACCATTCGACTTGGTACCACGA
CTGCGACTTGGGGTCGTAGTTGAGCAACGCGTCGGCCTTGGCCCACTTGTCCAGCATGTT
CAGCAGACAAGTGGCGTACACCGGCTTGCCCGTCGCAACGTAGAGATTTCCAAGCGTGGC
GGAAATTTTCTCGAAATCACGATAAAGCGTCACCACCGGTTCGTAGTCCGGATTCACCGG
GCCGTGATTGCCGGAAAGATAACGGCGCGGAATGACCATCTCGCCTTGCTGCGGGTTAGG
CGTTGCCTCGGTCGTGCAGTCGTACTCCTTGGGCAGCGCTGCCTTGAGGCGGTCATCGAG
CTGCCCGCTCTGCAAGAAGGTACGACGCGCCTTGACGTCGACATACGAGGCCGTGGGGTC
TTTCACGACGGCCTGGTCGAAGGGGTGTGCCTGCAGGCTGCCCGCGAAGGCACAACCTGC
GAACGCAAGCGCGGCGACGGCCAGACGACGGCCATGCCCCGGGAACGGGATGTCAAACAT
CGAACTGTCTCCAGATTTTTCGCGCGCAGCCCCCACGCGCGTCGTTGCAAGGCATGCCAA
AGGCAT

# Drug_Target_2_General_Function:
Involved in poly(beta-D-mannuronate) lyase activity

# Drug_Target_2_General_References:
10869078	Momma K, Okamoto M, Mishima Y, Mori S, Hashimoto W, Murata K: A novel bacterial ATP-binding cassette transporter system that allows uptake of macromolecules. J Bacteriol. 2000 Jul;182(14):3998-4004.

# Drug_Target_2_HGNC_ID:
Not Available

# Drug_Target_2_HPRD_ID:
Not Available

# Drug_Target_2_ID:
5696

# Drug_Target_2_Locus:
Not Available

# Drug_Target_2_Molecular_Weight:
71004

# Drug_Target_2_Name:
Alginate lyase

# Drug_Target_2_Number_of_Residues:
641

# Drug_Target_2_PDB_ID:
1HV6

# Drug_Target_2_Pathway:
Not Available

# Drug_Target_2_Pfam_Domain_Function:
PF05426	Alginate_lyase

# Drug_Target_2_Protein_Sequence:
>Alginate lyase
MPLACLATTRVGAAREKSGDSSMFDIPFPGHGRRLAVAALAFAGCAFAGSLQAHPFDQAV
VKDPTASYVDVKARRTFLQSGQLDDRLKAALPKEYDCTTEATPNPQQGEMVIPRRYLSGN
HGPVNPDYEPVVTLYRDFEKISATLGNLYVATGKPVYATCLLNMLDKWAKADALLNYDPK
SQSWYQVEWSAATAAFALSTMMAEPNVDTAQRERVVKWLNRVARHQTSFPGGDTSCCNNH
SYWRGQEATIIGVISKDDELFRWGLGRYVQAMGLINEDGSFVHEMTRHEQSLHYQNYAML
PLTMIAETASRQGIDLYAYKENGRDIHSARKFVFAAVKNPDLIKKYASEPQDTRAFKPGR
GDLNWIEYQRARFGFADELGFMTVPIFDPRTGGSGTLLAYKPQGAAAQAPVSAPAAAHSS
IDLSKWKLQIPVDPIDVATRDLLKGYQDKYFYVDKDGSLAFWCPASGFKTTANTKYPRSE
LREMLDPDNHAVNWGWQGTHEMNLRGAVMHVSPSGKTIVMQIHAVMPDGSNAPPLVKGQF
YKNTLDFLVKNSAAGGKDTHYVFEGIELGKPYDAQIKVVDGVLSMTVNGQTKTVDFVAKD
AGWKDLKFYFKAGNYLQDRQADGSDTSALVKLYKLDVKHSS

# Drug_Target_2_Reaction:
Not Available

# Drug_Target_2_Signals:
None

# Drug_Target_2_Specific_Function:
Not Available

# Drug_Target_2_SwissProt_ID:
Q9KWU1

# Drug_Target_2_SwissProt_Name:
Q9KWU1_SPHSX

# Drug_Target_2_Synonyms:
Not Available

# Drug_Target_2_Theoretical_pI:
8.06

# Drug_Target_2_Transmembrane_Regions:
None

# Drug_Target_3_Cellular_Location:
Cell wall
peptidoglycan-anchor (Potential)

# Drug_Target_3_Chromosome_Location:
Not Available

# Drug_Target_3_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_3_Essentiality:
Non-Essential

# Drug_Target_3_GenAtlas_ID:
Not Available

# Drug_Target_3_GenBank_ID_Gene:
AE005672

# Drug_Target_3_GenBank_ID_Protein:
14971788

# Drug_Target_3_GeneCard_ID:
Not Available

# Drug_Target_3_Gene_Name:
SP_0314

# Drug_Target_3_Gene_Sequence:
>3201 bp
ATGCAAACAAAAACAAAGAAGCTCATTGTGAGTTTGTCTTCACTTGTTTTATCAGGATTT
TTATTAAACCATTATATGACAATTGGAGCGGAAGAAACGACTACGAATACCATTCAGCAA
AGCCAGAAGGAAGTTCAGTATCAGCAAAGGGATACAAAAAATTTAGTTGAAAATGGTGAT
TTTGGTCAGACGGAGGACGGAAGCAGTCCGTGGACAGGAAGCAAAGCTCAGGGGTGGTCA
GCTTGGGTAGACCAGAAGAATAGTGCAGATGCCTCAACTCGAGTCATTGAGGCTAAGGAT
GGGGCTATCACTATCTCAAGCCATGAGAAATTAAGGGCAGCGCTTCACCGTATGGTTCCT
ATTGAAGCTAAGAAAAAGTATAAACTGCGTTTCAAGATTAAAACAGATAATAAAATCGGG
ATTGCCAAAGTTCGTATCATTGAGGAAAGTGGTAAGGACAAGCGATTGTGGAATTCTGCA
ACGACGTCAGGAACAAAGGACTGGCAGACCATTGAAGCAGACTATAGCCCGACTTTAGAT
GTTGATAAAATCAAGCTGGAGTTATTCTATGAAACAGGAACTGGGACTGTTTCCTTTAAG
GATATTGAGCTGGTAGAGGTAGCAGACCAGCTTTCTGAGGATTCTCAAACAGATAAACAG
CTTGAGGAAAAGATTGATTTACCAATTGGAAAAAAACATGTTTTTTCTCTTGCGGACTAT
ACTTATAAGGTAGAAAATCCTGACGTTGCTTCAGTCAAAAATGGAATTTTAGAACCTCTT
AAGGAAGGGACAACCAATGTCATTGTCAGTAAAGATGGCAAGGAAGTGAAAAAGATTCCT
TTGAAGATTCTGGCCTCTGTTAAGGATGCATACACAGACCGTTTGGATGACTGGAATGGC
ATCATCGCTGGGAATCAATACTATGATTCTAAAAATGAACAGATGGCCAAATTAAACCAG
GAATTGGAAGGAAAGGTAGCTGATAGCCTATCCAGTATTTCAAGTCAGGCGGACCGCACC
TATTTGTGGGAAAAATTTTCAAATTATAAAACGTCTGCAAATCTGACTGCCACTTATCGG
AAATTGGAGGAGATGGCCAAGCAAGTGACCAATCCTTCTTCTCGTTATTATCAAGATGAA
ACTGTCGTTCGAACAGTCAGGGATTCCATGGAATGGATGCATAAACATGTCTACAATAGT
GAAAAGAGCATTGTTGGGAACTGGTGGGATTATGAAATCGGTACACCTCGTGCCATCAAC
AATACCTTGTCTCTGATGAAAGAATACTTCTCTGATGAGGAAATTAAAAAATATACAGAT
GTGATTGAAAAATTTGTACCAGATCCCGAACATTTCCGAAAGACGACTGATAACCCATTC
AAGGCTCTAGGTGGAAACTTAGTTGATATGGGAAGGGTAAAAGTAATAGCTGGTTTACTG
CGTAAGGATGATCAAGAAATTTCTTCTACCATTCGCTCGATTGAGCAAGTGTTCAAGTTG
GTAGACCAAGGTGAAGGTTTTTATCAAGATGGATCCTATATCGACCACACCAATGTTGCC
TATACGGGTGCTTATGGGAATGTTTTGATTGATGGCCTGTCTCAACTGTTGCCAGTCATT
CAAAAGACCAAGAATCCAATCGATAAAGATAAAATGCAAACCATGTACCACTGGATTGAT
AAATCGTTTGCTCCTTTGCTGGTGAATGGAGAGTTGATGGATATGAGTCGTGGACGCTCG
ATCAGTCGTGCAAATAGCGAGGGGCACGTGGCCGCAGTAGAAGTACTAAGAGGGATTCAC
CGAATAGCGGATATGTCTGAAGGAGAAACCAAACAATGTTTGCAGAGTCTTGTGAAGACC
ATTGTTCAATCGGATAGTTATTATGATGTCTTTAAGAATTTGAAGACTTATAAGGATATC
AGTTTGATGCAATCCTTGTTAAGTGATGCAGGAGTCGCAAGTGTTCCAAGACCAAGTTAC
CTATCTGCCTTTAACAAGATGGATAAAACAGCCATGTACAATGCAGAGAAAGGGTTTGGA
TTTGGCTTGTCACTCTTTTCCAGTCGTACCTTGAATTACGAACACATGAACAAGGAAAAT
AAACGTGGTTGGTATACGAGTGATGGGATGTTCTATCTTTACAATGGCGATTTGAGTCAC
TATAGCGATGGCTACTGGCCAACAGTTAATCCATATAAGATGCCTGGTACAACAGAGACG
GATGCTAAGAGAGCGGATAGCGATACAGGTAAAGTTTTACCGTCTGCTTTCGTTGGAACG
AGCAAACTAGATGATGCCAATGCGACAGCAACCATGGATTTCACCAACTGGAATCAAACA
TTGACTGCTCATAAGAGCTGGTTTATGCTAAAGGATAAGATCGCCTTTTTAGGAAGCAAT
ATCCAAAACACTTCAACAGATACTGCTGCAACTACAATTGACCAGAGAAAACTGGAATCA
GGTAATCCATATAAAGTCTATGTCAATGATAAAGAAGCCTCCCTTACAGAACAAGAAAAG
GATTATCCTGAAACCCAAAGTGTCTTTTTAGAATCGTTCGATTCGAAAAAGAATATTGGT
TACTTTTTCTTTAAGAAGAGTTCAATCAGTATGAGTAAGGCTTTGCAAAAGGGAGCCTGG
AAGGATATCAATGAAGGACAGTCAGACAAGGAAGTTGAAAATGAATTTCTTACGATTAGT
CAGGCTCATAAGCAAAATAGAGATTCTTATGGCTATATGCTCATTCCTAACGTGGATCGT
GCCACCTTCAATCAAATGATAAAAGAGTTAGAAAGTAGCCTCATCGAAAATAACGAAACC
CTTCAGTCTGTTTATGATGCTAAACAAGGAGTTTGGGGCATTGTGAAATATGATGATTCT
GTCTCTACTATTTCCAACCAATTCCAAGTTTTGAAACGTGGAGTCTATACCATTCGAAAA
GAAGGGGATGAATATAAGATTGCCTACTATAATCCTGAAACCCAGGAATCAGCTCCAGAT
CAGGAAGTCTTTAAAAAGCTAGAGCAAGCAGCTCAGCCACAAGTACAGAATTCAAAAGAA
AAGGAAAAATCTGAAGAGGAAAAGAACCATTCGGATCAAAAGAATCTCCCTCAGACAGGA
GAAGGTCAGTCAATCTTGGCAAGTCTAGGGTTCTTGCTACTTGGGGCATTTTATCTATTC
CGTAGAGGAAAGAACAACTAA

# Drug_Target_3_General_Function:
Involved in hyaluronidase activity

# Drug_Target_3_General_References:
11463916	Tettelin H, Nelson KE, Paulsen IT, Eisen JA, Read TD, Peterson S, Heidelberg J, DeBoy RT, Haft DH, Dodson RJ, Durkin AS, Gwinn M, Kolonay JF, Nelson WC, Peterson JD, Umayam LA, White O, Salzberg SL, Lewis MR, Radune D, Holtzapple E, Khouri H, Wolf AM, Utterback TR, Hansen CL, McDonald LA, Feldblyum TV, Angiuoli S, Dickinson T, Hickey EK, Holt IE, Loftus BJ, Yang F, Smith HO, Venter JC, Dougherty BA, Morrison DA, Hollingshead SK, Fraser CM: Complete genome sequence of a virulent isolate of Streptococcus pneumoniae. Science. 2001 Jul 20;293(5529):498-506.
8112843	Berry AM, Lock RA, Thomas SM, Rajan DP, Hansman D, Paton JC: Cloning and nucleotide sequence of the Streptococcus pneumoniae hyaluronidase gene and purification of the enzyme from recombinant Escherichia coli. Infect Immun. 1994 Mar;62(3):1101-8.
9573623	Jedrzejas MJ, Chantalat L, Mewbourne RB: Crystallization and preliminary X-ray analysis of Streptococcus pneumoniae hyaluronate lyase. J Struct Biol. 1998 Jan;121(1):73-5.

# Drug_Target_3_HGNC_ID:
Not Available

# Drug_Target_3_HPRD_ID:
Not Available

# Drug_Target_3_ID:
2485

# Drug_Target_3_Locus:
Not Available

# Drug_Target_3_Molecular_Weight:
120772

# Drug_Target_3_Name:
Hyaluronate lyase

# Drug_Target_3_Number_of_Residues:
1066

# Drug_Target_3_PDB_ID:
1OJO

# Drug_Target_3_Pathway:
Not Available

# Drug_Target_3_Pfam_Domain_Function:
PF00746	Gram_pos_anchor
PF02018	CBM_4_9
PF02278	Lyase_8
PF02884	Lyase_8_C
PF08124	Lyase_8_N

# Drug_Target_3_Protein_Sequence:
>Hyaluronate lyase precursor
MQTKTKKLIVSLSSLVLSGFLLNHYMTIGAEETTTNTIQQSQKEVQYQQRDTKNLVENGD
FGQTEDGSSPWTGSKAQGWSAWVDQKNSADASTRVIEAKDGAITISSHEKLRAALHRMVP
IEAKKKYKLRFKIKTDNKIGIAKVRIIEESGKDKRLWNSATTSGTKDWQTIEADYSPTLD
VDKIKLELFYETGTGTVSFKDIELVEVADQLSEDSQTDKQLEEKIDLPIGKKHVFSLADY
TYKVENPDVASVKNGILEPLKEGTTNVIVSKDGKEVKKIPLKILASVKDAYTDRLDDWNG
IIAGNQYYDSKNEQMAKLNQELEGKVADSLSSISSQADRTYLWEKFSNYKTSANLTATYR
KLEEMAKQVTNPSSRYYQDETVVRTVRDSMEWMHKHVYNSEKSIVGNWWDYEIGTPRAIN
NTLSLMKEYFSDEEIKKYTDVIEKFVPDPEHFRKTTDNPFKALGGNLVDMGRVKVIAGLL
RKDDQEISSTIRSIEQVFKLVDQGEGFYQDGSYIDHTNVAYTGAYGNVLIDGLSQLLPVI
QKTKNPIDKDKMQTMYHWIDKSFAPLLVNGELMDMSRGRSISRANSEGHVAAVEVLRGIH
RIADMSEGETKQCLQSLVKTIVQSDSYYDVFKNLKTYKDISLMQSLLSDAGVASVPRPSY
LSAFNKMDKTAMYNAEKGFGFGLSLFSSRTLNYEHMNKENKRGWYTSDGMFYLYNGDLSH
YSDGYWPTVNPYKMPGTTETDAKRADSDTGKVLPSAFVGTSKLDDANATATMDFTNWNQT
LTAHKSWFMLKDKIAFLGSNIQNTSTDTAATTIDQRKLESGNPYKVYVNDKEASLTEQEK
DYPETQSVFLESFDSKKNIGYFFFKKSSISMSKALQKGAWKDINEGQSDKEVENEFLTIS
QAHKQNRDSYGYMLIPNVDRATFNQMIKELESSLIENNETLQSVYDAKQGVWGIVKYDDS
VSTISNQFQVLKRGVYTIRKEGDEYKIAYYNPETQESAPDQEVFKKLEQAAQPQVQNSKE
KEKSEEEKNHSDQKNLPQTGEGQSILASLGFLLLGAFYLFRRGKNN

# Drug_Target_3_Reaction:
Cleaves hyaluronate chains at a beta-D-GalNAc-(1->4)-beta-D-GlcA bond, ultimately breaking the polysaccharide down to 3-(4-deoxy-beta-D-gluc-4-enuronosyl)-N-acetyl-D-glucosamine

# Drug_Target_3_Signals:
1-30

# Drug_Target_3_Specific_Function:
Cleaves hyaluronate chains at a beta-D-GalNAc- (1->4)-beta-D-GlcA bond, ultimately breaking the polysaccharide down to 3-(4-deoxy-beta-D-gluc-4-enuronosyl)-N-acetyl-D- glucosamine

# Drug_Target_3_SwissProt_ID:
Q54873

# Drug_Target_3_SwissProt_Name:
HYSA_STRPN

# Drug_Target_3_Synonyms:
EC 4.2.2.1
HYase
Hyaluronate lyase precursor
Hyaluronidase

# Drug_Target_3_Theoretical_pI:
5.97

# Drug_Target_3_Transmembrane_Regions:
None

# Drug_Target_4_Cellular_Location:
Not Available

# Drug_Target_4_Chromosome_Location:
Not Available

# Drug_Target_4_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_4_Essentiality:
Non-Essential

# Drug_Target_4_GenAtlas_ID:
Not Available

# Drug_Target_4_GenBank_ID_Gene:
U27584

# Drug_Target_4_GenBank_ID_Protein:
1002527

# Drug_Target_4_GeneCard_ID:
Not Available

# Drug_Target_4_Gene_Name:
cslB

# Drug_Target_4_Gene_Sequence:
>1521 bp
ATGAAGATGCTGAATAAACTAGCCGGATACTTATTGCCGATCATGGTGCTGCTGAATGTG
GCACCATGCTTAGGTCAGGTTGTTGCTTCAAATGAAACTTTATACCAGGTTGTAAAGGAG
GTAAAACCCGGTGGTCTGGTACAGATTGCCGATGGGACTTATAAAGATGTTCAGCTGATT
GTCAGCAATTCAGGAAAATCTGGTTTGCCCATCACTATTAAAGCCCTGAACCCGGGTAAG
GTTTTTTTTACCGGAGATGCTAAAGTAGAGCTGAGGGGCGAGCACCTGATACTGGAAGGC
ATCTGGTTTAAAGACGGGAACAGAGCTATTCAGGCATGGAAATCACATGGACCCGGATTG
GTGGCTATATATGGTAGCTATAACCGCATTACCGCATGTGTATTTGATTGTTTTGATGAA
GCCAATTCTGCTTACATTACTACTTCGCTTACCGAAGACGGAAAGGTACCTCAACATTGC
CGCATAGACCATTGCAGTTTTACCGATAAGATCACTTTTGACCAGGTAATTAACCTGAAC
AATACAGCCAGAGCTATTAAAGACGGTTCGGTGGGAGGACCGGGGATGTACCATCGTGTT
GATCACTGTTTTTTTTCCAATCCGCAAAAACCGGGTAATGCCGGAGGGGGAATCAGGATT
GGCTATTACCGTAATGATATAGGCCGTTGTCTGGTAGACTCTAACCTGTTTATGCGTCAG
GATTCGGAAGCAGAGATCATCACCAGCAAATCGCAGGAAAATGTTTATTATGGTAATACT
TACCTGAATTGCCAGGGCACCATGAACTTTCGTCACGGTGATCATCAGGTGGCCATTAAC
AATTTTTATATAGGCAATGACCAGCGATTTGGATACGGGGGAATGTTTGTTTGGGGAAGC
AGGCATGTCATAGCCTGTAATTATTTTGAGCTGTCCGAAACCATAAAGTCGAGGGGGAAC
GCCGCATTGTATTTAAACCCCGGTGCTATGGCTTCGGAGCATGCTCTTGCTTTCGATATG
TTGATAGCCAACAACGCTTTCATCAATGTAAATGGGTATGCCATCCATTTTAATCCATTG
GATGAGCGCAGAAAAGAATATTGTGCAGCCAATAGGCTTAAGTTCGAAACCCCGCACCAG
CTAATGTTAAAAGGCAATCTTTTCTTTAAGGATAAACCTTATGTTTACCCATTTTTTAAA
GATGATTATTTTATAGCAGGGAAAAATAGCTGGACTGGTAATGTAGCCTTAGGTGTGGAA
AAGGGAATCCCTGTTAACATTTCGGCCAATAGGTCTGCCTATAAGCCGGTAAAAATTAAA
GATATCCAGCCCATAGAAGGAATCGCTCTTGATCTCAATGCGCTGATCAGCAAAGGCATT
ACAGGAAAGCCCCTTAGCTGGGATGAAGTAAGGCCCTACTGGTTAAAAGAAATGCCCGGG
ACGTATGCTTTAACGGCCAGGCTTTCTGCAGATAGGGCTGCAAAGTTTAAAGCCGTAATT
AAAAGAAATAAAGAGCACTGA

# Drug_Target_4_General_Function:
Not Available

# Drug_Target_4_General_References:
10600383	Huang W, Matte A, Li Y, Kim YS, Linhardt RJ, Su H, Cygler M: Crystal structure of chondroitinase B from Flavobacterium heparinum and its complex with a disaccharide product at 1.7 A resolution. J Mol Biol. 1999 Dec 17;294(5):1257-69.
10618199	Tkalec AL, Fink D, Blain F, Zhang-Sun G, Laliberte M, Bennett DC, Gu K, Zimmermann JJ, Su H: Isolation and expression in Escherichia coli of cslA and cslB, genes coding for the chondroitin sulfate-degrading enzymes chondroitinase AC and chondroitinase B, respectively, from Flavobacterium heparinum. Appl Environ Microbiol. 2000 Jan;66(1):29-35.
11327856	Huang W, Boju L, Tkalec L, Su H, Yang HO, Gunay NS, Linhardt RJ, Kim YS, Matte A, Cygler M: Active site of chondroitin AC lyase revealed by the structure of enzyme-oligosaccharide complexes and mutagenesis. Biochemistry. 2001 Feb 27;40(8):2359-72.
12063249	Pojasek K, Raman R, Kiley P, Venkataraman G, Sasisekharan R: Biochemical characterization of the chondroitinase B active site. J Biol Chem. 2002 Aug 23;277(34):31179-86. Epub 2002 Jun 12.

# Drug_Target_4_HGNC_ID:
Not Available

# Drug_Target_4_HPRD_ID:
Not Available

# Drug_Target_4_ID:
2430

# Drug_Target_4_Locus:
Not Available

# Drug_Target_4_Molecular_Weight:
56323

# Drug_Target_4_Name:
Chondroitinase B

# Drug_Target_4_Number_of_Residues:
506

# Drug_Target_4_PDB_ID:
1DBO

# Drug_Target_4_Pathway:
Not Available

# Drug_Target_4_Pfam_Domain_Function:
Not Available

# Drug_Target_4_Protein_Sequence:
>Chondroitinase B precursor
MKMLNKLAGYLLPIMVLLNVAPCLGQVVASNETLYQVVKEVKPGGLVQIADGTYKDVQLI
VSNSGKSGLPITIKALNPGKVFFTGDAKVELRGEHLILEGIWFKDGNRAIQAWKSHGPGL
VAIYGSYNRITACVFDCFDEANSAYITTSLTEDGKVPQHCRIDHCSFTDKITFDQVINLN
NTARAIKDGSVGGPGMYHRVDHCFFSNPQKPGNAGGGIRIGYYRNDIGRCLVDSNLFMRQ
DSEAEIITSKSQENVYYGNTYLNCQGTMNFRHGDHQVAINNFYIGNDQRFGYGGMFVWGS
RHVIACNYFELSETIKSRGNAALYLNPGAMASEHALAFDMLIANNAFINVNGYAIHFNPL
DERRKEYCAANRLKFETPHQLMLKGNLFFKDKPYVYPFFKDDYFIAGKNSWTGNVALGVE
KGIPVNISANRSAYKPVKIKDIQPIEGIALDLNALISKGITGKPLSWDEVRPYWLKEMPG
TYALTARLSADRAAKFKAVIKRNKEH

# Drug_Target_4_Reaction:
Eliminative cleavage of dermatan sulfate containing 1,4-beta-D-hexosaminyl and 1,3-beta-D-glucurosonyl or 1,3-alpha-L-iduronosyl linkages to disaccharides containing 4-deoxy-beta-D-gluc-4-enuronosyl groups to yield a 4,5-unsaturated dermatan-sulfate disaccharide (deltaUA-GalNAc-4S).

# Drug_Target_4_Signals:
1-25

# Drug_Target_4_Specific_Function:
Cleaves the glycosaminoglycan, dermatan sulfate

# Drug_Target_4_SwissProt_ID:
Q46079

# Drug_Target_4_SwissProt_Name:
CSLB_PEDHD

# Drug_Target_4_Synonyms:
Chondroitin B eliminase
Chondroitin B lyase
Chondroitin sulfate B lyase
Chondroitinase B precursor
EC 4.2.2.19

# Drug_Target_4_Theoretical_pI:
8.94

# Drug_Target_4_Transmembrane_Regions:
None

#END_DRUGCARD DB04548
